In Vivo Xenograft Models of Breast Cancer Metastasis
If breast cancer patients are not cured, it is largely because of the fact that the cancer has spread beyond its primary site—the breast—to distant sites, such as, e.g., bone marrow, lung, brain, and/or liver. These secondary tumors are called metastases , and the underlying mechanisms leading to these secondary tumor deposits are complex and still ill understood. In this chapter, we report on how to develop clinically relevant human breast cancer cell line xenografts in severe combined immunodeficient mice. In severe combined immunodeficient mice, metastasizing human breast cancer cell lines were identified by their ability to bind the lectin Helix pomatia agglutinin, which was identified as a marker of metastasis in clinical studies. This model system was created to help to define the rate-limiting steps of the metastatic cascade.
- Deep Transcriptome Profiling of Ovarian Cancer Cells Using Next-Generation Sequencing Approach
- Immunophenotyping of Plasma Cells in Multiple Myeloma
- Assaying the Spindle Checkpoint in the Budding Yeast Saccharomyces cerevisiae
- The EGFR Pathway as an Example for Genotype: Phenotype Correlation in Tumor Genes
- MicroRNA Profiling in Ovarian Cancer
- Use of Proteomics to Study Chemosensitivity
- Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells
- Cross-linking Subtractive Hybridization to Identify Tumor Suppressor Genes
- Transgenic Animal Models
- 外源基因在真核细胞表达步骤